Atlas Trials

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Clinical trial NCT01964989 · COMPLETED

Trial details

NCT number
NCT01964989
Sponsor
Seqirus
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza Virus
Start date
2013-11-01
Primary completion
2015-10-01
Enrollment
10644

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.